RVMD

← Markets

RVMDRevolution Medicines, Inc.

+0.63

Signal

Stories4

Sources2

Heat0.7

Discussion

Nothing said here yet.

to join the conversation.


GOLDSMITH MARK ASee Remarks	Sell	35,938	$7.5M	Fri, Aug 21
Cislini JeffGeneral Counsel	Sell	25,817	$5.4M	Fri, Aug 21
GOLDSMITH MARK ASee Remarks	Sell	24,917	$5.2M	Fri, Aug 21
Cislini JeffGeneral Counsel	Sell	17,323	$3.6M	Fri, Aug 21
GOLDSMITH MARK ASee Remarks	Sell	6,583	$1.4M	Fri, Aug 21
GOLDSMITH MARK ASee Remarks	Sell	5,128	$1.1M	Fri, Aug 21
Cislini JeffGeneral Counsel	Sell	4,500	$951.0K	Fri, Aug 21
GOLDSMITH MARK ASee Remarks	Sell	3,813	$801.7K	Fri, Aug 21
GOLDSMITH MARK ASee Remarks	Sell	3,621	$767.9K	Fri, Aug 21
Cislini JeffGeneral Counsel	Sell	3,400	$704.6K	Fri, Aug 21
Cislini JeffGeneral Counsel	Sell	3,314	$702.8K	Fri, Aug 21
Cislini JeffGeneral Counsel	Sell	2,540	$534.1K	Fri, Aug 21

GOLDSMITH MARK ASee Remarks

Sell

35,938

$7.5M

Fri, Aug 21

Cislini JeffGeneral Counsel

Sell

25,817

$5.4M

Fri, Aug 21

GOLDSMITH MARK ASee Remarks

Sell

24,917

$5.2M

Fri, Aug 21

Cislini JeffGeneral Counsel

Sell

17,323

$3.6M

Fri, Aug 21

GOLDSMITH MARK ASee Remarks

Sell

6,583

$1.4M

Fri, Aug 21

GOLDSMITH MARK ASee Remarks

Sell

5,128

$1.1M

Fri, Aug 21

Cislini JeffGeneral Counsel

Sell

4,500

$951.0K

Fri, Aug 21

GOLDSMITH MARK ASee Remarks

Sell

3,813

$801.7K

Fri, Aug 21

GOLDSMITH MARK ASee Remarks

Sell

3,621

$767.9K

Fri, Aug 21

Cislini JeffGeneral Counsel

Sell

3,400

$704.6K

Fri, Aug 21

Cislini JeffGeneral Counsel

Sell

3,314

$702.8K

Fri, Aug 21

Cislini JeffGeneral Counsel

Sell

2,540

$534.1K

Fri, Aug 21

Fri, Aug 28
4:11 PMYahooIncyte Corporation (INCY) vs. Revolution Medicines (RVMD): Which Biotech Stock Offers the Better KRAS Opportunity?
3:54 PMYahooRevolution Medicines (RVMD) Made Pancreatic-Cancer History. At $47B Valuation, the Market Already Assumed It
2:02 PMmarketbeat.comRevolution Medicines Wins FDA Approval for RASONQUE in Metastatic Pancreatic Cancer
11:18 AMYahooRevolution Medicines Set to Post 'Strong Launch' for Rasonque, UBS Says
6:27 AMYahooRevolution Medicines Won FDA Approval One Month After Filing. Analysts See $11.5 Billion in Peak Sales. Is the Stock Still a Buy After Skyrocketing More Than 5X?
1:18 AMYahooRevolution Medicines (RVMD) After RASONQUE Approval Is The Valuation Story Still Intact
Thu, Aug 27
6:12 PMYahooHow Investors Are Reacting To Revolution Medicines (RVMD) First-in-Class RASONQUE Approval In Pancreatic Cancer
2:11 PMYahooWhat Does Revolution Medicines (RVMD) Approval Mean For Metastatic Pancreatic Cancer?
1:54 PMstocktwits.comRevolution Medicine’s $39,800-Monthly Cancer Drug Puts Access In Focus — CEO Goldsmith Expects Insurers To Move ‘Swiftly’ To Provide Coverage
12:00 PMYahooRVMD Secures FDA Win, Gets Nod for Rasonque in Pancreatic Cancer
11:21 AMYahooRevolution Medicines' Rasonque Label Expands Commercial Opportunity, Oppenheimer Says
Wed, Aug 26
5:22 PMstocktwits.comSellas Traders See Pancreatic Cancer Race After RVMD’s Drug Approval — But Near-Term Focus Remains On SLS’s Leukemia Pipeline